Subchap A — General
Search Subchapter A full text →
- Pt. 1 General Enforcement Regulations §§1.1 to 1.1465
- Pt. 2 General Administrative Rulings and Decisions §§2.5 to 2.125
- Pt. 3 Product Jurisdiction §§3.1 to 3.10
- Pt. 4 Regulation of Combination Products §§4.1 to 4.105
- Pt. 5 Organization §5.1100
- Pt. 7 Enforcement Policy §§7.1 to 7.87
- Pt. 10 Administrative Practices and Procedures §§10.1 to 10.206
- Pt. 11 Electronic Records; Electronic Signatures §§11.1 to 11.300
- Pt. 12 Formal Evidentiary Public Hearing §§12.1 to 12.159
- Pt. 13 Public Hearing Before a Public Board of Inquiry §§13.1 to 13.50
- Pt. 14 Public Hearing Before a Public Advisory Committee §§14.1 to 14.174
- Pt. 15 Public Hearing Before the Commissioner §§15.1 to 15.45
- Pt. 16 Regulatory Hearing Before the Food and Drug Administration §§16.1 to 16.120
- Pt. 17 Civil Money Penalties Hearings §§17.1 to 17.54
- Pt. 19 Standards of Conduct and Conflicts of Interest §§19.1 to 19.55
- Pt. 20 Public Information §§20.1 to 20.120
- Pt. 21 Protection of Privacy §§21.1 to 21.75
- Pt. 25 Environmental Impact Considerations §§25.1 to 25.60
- Pt. 50 Protection of Human Subjects §§50.1 to 50.56
- Pt. 54 Financial Disclosure by Clinical Investigators §§54.1 to 54.6
- Pt. 56 Institutional Review Boards §§56.101 to 56.124
- Pt. 58 Good Laboratory Practice for Nonclinical Laboratory Studies §§58.1 to 58.219
- Pt. 60 Patent Term Restoration §§60.1 to 60.46
- Pt. 70 Color Additives §§70.3 to 70.55
- Pt. 71 Color Additive Petitions §§71.1 to 71.37
- Pt. 73 Listing of Color Additives Exempt from Certification §§73.1 to 73.3129
- Pt. 74 Listing of Color Additives Subject to Certification §§74.101 to 74.3710
- Pt. 80 Color Additive Certification §§80.10 to 80.39
- Pt. 81 General Specifications and General Restrictions for Provisional Color Additives for Use in Foods, Drugs, and Cosmetics §§81.1 to 81.30
- Pt. 82 Listing of Certified Provisionally Listed Colors and Specifications §§82.3 to 82.2707a
- Pt. 83-98 Parts 83-98 [reserved]
- Pt. 99 Dissemination of Information on Unapproved/new Uses for Marketed Drugs, Biologics, and Devices §§99.1 to 99.501